HK88396A - 24r-scymnol, and preparation and use thereof - Google Patents

24r-scymnol, and preparation and use thereof

Info

Publication number
HK88396A
HK88396A HK88396A HK88396A HK88396A HK 88396 A HK88396 A HK 88396A HK 88396 A HK88396 A HK 88396A HK 88396 A HK88396 A HK 88396A HK 88396 A HK88396 A HK 88396A
Authority
HK
Hong Kong
Prior art keywords
scymnol
compound
preparation
hydrolysis
activity
Prior art date
Application number
HK88396A
Other languages
German (de)
English (en)
French (fr)
Inventor
Kosuge Yoshiki
Kosuge Takuo
Tsuji Kuniro
Ishida Hitoshi
Original Assignee
J. W. Broadbent Nominees Pty. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by J. W. Broadbent Nominees Pty. Ltd. filed Critical J. W. Broadbent Nominees Pty. Ltd.
Publication of HK88396A publication Critical patent/HK88396A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polymerisation Methods In General (AREA)
  • Glass Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK88396A 1988-02-19 1996-05-23 24r-scymnol, and preparation and use thereof HK88396A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPI685088 1988-02-19

Publications (1)

Publication Number Publication Date
HK88396A true HK88396A (en) 1996-05-31

Family

ID=3772839

Family Applications (1)

Application Number Title Priority Date Filing Date
HK88396A HK88396A (en) 1988-02-19 1996-05-23 24r-scymnol, and preparation and use thereof

Country Status (14)

Country Link
EP (1) EP0401262B1 (da)
JP (1) JP2716827B2 (da)
AT (1) ATE132500T1 (da)
AU (1) AU609959B2 (da)
CA (1) CA1328104C (da)
DE (1) DE68925355T2 (da)
DK (1) DK167220B1 (da)
ES (1) ES2013025A6 (da)
GR (1) GR1001203B (da)
HK (1) HK88396A (da)
NZ (1) NZ228023A (da)
PT (1) PT89742B (da)
WO (1) WO1989007607A1 (da)
ZA (1) ZA891242B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU597723B2 (en) * 1986-08-21 1990-06-07 J.W. Broadbent Nominees Pty. Ltd. Sodium scymnol sulphate isolated form shark tissues
WO1992000316A1 (fr) * 1990-06-30 1992-01-09 Tsumura & Co., Ltd. Alcool biliaire et medicament contenant cet alcool comme ingredient actif
ZA947912B (en) * 1993-10-12 1995-05-24 Broadbent J W Nominees Pty Ltd Treatment of medical disorders associated with free radical formation
KR20010043558A (ko) * 1998-05-13 2001-05-25 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 감수분열 조절 화합물
CN100383157C (zh) * 2006-06-01 2008-04-23 中国科学院南海海洋研究所 3β，5α，6β，11β-四羟基胆甾烷醇及其制备方法和用途
US20090104221A1 (en) 2007-07-06 2009-04-23 Vaxdesign Corporation Rapid generation of t cell-independent antibody responses to t cell-dependent antigens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931403A (en) * 1973-05-25 1976-01-06 Intellectual Property Development Corporation Antimicrobial compositions

Also Published As

Publication number Publication date
GR1001203B (el) 1993-06-21
JPH03503407A (ja) 1991-08-01
DK167220B1 (da) 1993-09-20
AU3186189A (en) 1989-09-06
PT89742B (pt) 1994-03-31
DK192890D0 (da) 1990-08-14
CA1328104C (en) 1994-03-29
DK192890A (da) 1990-08-14
ES2013025A6 (es) 1990-04-16
EP0401262A4 (en) 1993-05-05
EP0401262A1 (en) 1990-12-12
NZ228023A (en) 1991-10-25
AU609959B2 (en) 1991-05-09
PT89742A (pt) 1989-10-04
EP0401262B1 (en) 1996-01-03
JP2716827B2 (ja) 1998-02-18
ATE132500T1 (de) 1996-01-15
DE68925355D1 (de) 1996-02-15
ZA891242B (en) 1989-10-25
WO1989007607A1 (en) 1989-08-24
DE68925355T2 (de) 1996-08-01

Similar Documents

Publication Publication Date Title
EP0223403B1 (en) Piperidine derivative, its preparation, and its use as medicament
IE891142L (en) Gabapentin monohydrate and a process for producing the same
KR930002492B1 (ko) 6-티오크산틴 유도체의 제조방법
US5354760A (en) Crystalline Tiagabine monohydrate, its preparation and use
EP0401262B1 (en) 24r-scymnol, and preparation and use thereof
US5760009A (en) Spirostanyl glycosidal crystalline monohydrate
EP0228625B1 (de) Peptid-Derivate mit inhibitorischer Wirkung auf hydroxylierende Enzyme, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung
EP0464927A2 (en) 3-[(5-Methyl-2-furanyl)methyl]-N-(4-piperidinyl)-3H-imidazo[4,5-b]-pyridin-2-amine 2-hydroxy-1,2,3-propanetricarboxylate
CA2433190C (en) Amlodipine hemimaleate
EP0193965A2 (en) Novel guanidinomethylcyclohexancarboxylic acid compounds, processes for preparing them, and pharmaceutical compositions containing them
US5081149A (en) Antihepatopathic method
JPH09510735A (ja) スピロスタニルグリコシド性結晶
US5326782A (en) Salts derived from 26-(dialkylaminoalkylsulphonyl)pristinamycin IIB
EP0069527B1 (en) Cystine derivatives
US4034045A (en) 2,4-Disubstituted-4b,5,6,7,8,8a,9,10-octahydro-9-oxo-phenanthrenes
US4042594A (en) The hypolipidemic agent, 4-(4-chlorobenzyloxy)-benzyl nicotinate and preparation thereof
US4588526A (en) Bronchodilatory azepino(1,2-A)pyrimidine derivatives and acid addition salts thereof and bronchodilating pharmaceutical compositions containing same
US3888853A (en) 1,2,5,6-tetrahydropyridines
HU198012B (en) Process for producing cyclic amino-acid derivatives and pharmaceutical compositions containing them
US4148904A (en) Anti-ulcer composition
JPH0459792A (ja) ジエチレントリアミン三酢酸オキシアルキルエステル化合物及びそれらの製造法
EP0298890A2 (en) New 2-(P-isobutylphenyl)-propionic acid ester and process for the preparation thereof
JPH08501793A (ja) １，２‐ジヒドロ‐２‐オキソ‐３‐アミノキノキサリン誘導体、その製法およびその治療上の応用
JPH0123478B2 (da)
PL202147B1 (pl) Sposób oczyszczania chlorowodorku daunorubicyny

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)